| 論文 |
papers |
-
FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells. Makoto Matsumoto,Riku Takayama,Chiemi Matsuguchi,Haruki Shimada,Tatsunori Izumi,Naoya Kato,Ayaka Matsuo-Tani,Hikaru Nakamura,Takeshi Hiu,Takayuki Matsuo,Hidefumi Mukai,Shigeru Kawakami European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 226巻107645頁-107645頁 2026年08月18日
-
Protein-based pan-RAS inhibitor induces tumor regression in female mice via IFNγ and CD8+ T cell-dependent tumor necrosis. Teiko Komori Nomura,Kazuki Heishima,Hidefumi Mukai,Kosuke Arai,Abdelazim Elsayed Elhelaly,Hirobumi Fuchigami,Shota Warashina,Tsuyoshi Tahara,Fuminori Hyodo,Masayuki Matsuo,Masahiro Yasunaga,Kazunori Aoki,Ryo Honda Nature communications 17巻1号 2026年05月16日
-
Microfluidic post-insertion preparation and evaluation of RGD- and PEG-modified macrophage-derived small extracellular vesicles Mizuki Umino,Longjian Geng,Yusuke Ushiroda,Makoto Matsumoto,Hidefumi Mukai,Shigeru Kawakami Drug Metabolism and Pharmacokinetics 101538頁-101538頁 2026年04月
-
Metabolic positron emission tomography imaging and tumor growth inhibition during the Q neuron-induced hibernation-like state in mice. Shoko Nomura,Wakiko Arakaki,Akari Kato,Naomi Fujie,Kiyomi Ishikawa,Ayaka Wataki,Hiroaki Ono,Tsuyoshi Tahara,Yasuhiro Wada,Yasuyoshi Watanabe,Hisashi Doi,Genshiro A Sunagawa,Hidefumi Mukai Biochemical and biophysical research communications 800巻153268頁-153268頁 2026年01月12日
-
Targeted Delivery of VEGF-siRNA to Glioblastoma Using Orientation-Controlled Anti-PD-L1 Antibody-Modified Lipid Nanoparticles. Ayaka Matsuo-Tani,Makoto Matsumoto,Takeshi Hiu,Mariko Kamiya,Longjian Geng,Riku Takayama,Yusuke Ushiroda,Naoya Kato,Hikaru Nakamura,Michiharu Yoshida,Hidefumi Mukai,Takayuki Matsuo,Shigeru Kawakami Pharmaceutics 17巻10号 2025年10月04日
-
Positron Emission Tomography-Based Pharmacokinetics of mRNA–Lipid Nanoparticles: A Study Quantifying the ApoE and Macrophage Contribution Kohta Mohri,Takayuki Miyazaki,Shota Warashina,Maiko Takahashi,Qin Ren,Riho Iida,Yasuhiro Wada,Kazuya Maeda,Yasuyoshi Watanabe,Yuta Suzuki,Hidefumi Mukai ACS Applied Materials & Interfaces 2025年08月03日
-
Direct delivery of immune modulators to tumour-infiltrating lymphocytes using engineered extracellular vesicles. Xiabing Lyu,Tomoyoshi Yamano,Kanto Nagamori,Shota Imai,Toan Van Le,Dilireba Bolidong,Makie Ueda,Shota Warashina,Hidefumi Mukai,Seigo Hayashi,Kazutaka Matoba,Taito Nishino,Rikinari Hanayama Journal of extracellular vesicles 14巻4号e70035頁- 2025年04月
-
Tumor-stromal opening via S. typhimurium VNP20009 administration for complete inhibition of refractory tumor growth with liposomal anticancer drugs Akari Kato,Shoko Nomura,Maiko Takahashi,Erike Widyasari Sukowati,Hideyoshi Harashima,Hidefumi Mukai Journal of Controlled Release 2025年02月
-
Microfluidic post-insertion of polyethylene glycol lipids and KK or RGD high functionality and quality lipids in milk-derived extracellular vesicles. Longjian Geng,Makoto Matsumoto,Feijie Yao,Mizuki Umino,Mariko Kamiya,Hidefumi Mukai,Shigeru Kawakami European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 106929頁-106929頁 2024年10月08日
-
Synthesis of a novel adapter lipid using Fc-region mediated antibody modification for post-insert preparation of transferrin receptor targeted messenger RNA-loaded lipid nanoparticles Naoya Kato,Narumi Moriya,Makoto Matsumoto,Ayaka Matsuo,Michiharu Yoshida,Takeshi Hiu,Takayuki Matsuo,Yuuki Takashima,Mariko Kamiya,Hidefumi Mukai,Shigeru Kawakami European Journal of Pharmaceutics and Biopharmaceutics 114468頁-114468頁 2024年08月
-
FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells. Makoto Matsumoto,Riku Takayama,Chiemi Matsuguchi,Haruki Shimada,Tatsunori Izumi,Naoya Kato,Ayaka Matsuo-Tani,Hikaru Nakamura,Takeshi Hiu,Takayuki Matsuo,Hidefumi Mukai,Shigeru Kawakami European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 226.107645-107645 2026/08/18
-
Protein-based pan-RAS inhibitor induces tumor regression in female mice via IFNγ and CD8+ T cell-dependent tumor necrosis. Teiko Komori Nomura,Kazuki Heishima,Hidefumi Mukai,Kosuke Arai,Abdelazim Elsayed Elhelaly,Hirobumi Fuchigami,Shota Warashina,Tsuyoshi Tahara,Fuminori Hyodo,Masayuki Matsuo,Masahiro Yasunaga,Kazunori Aoki,Ryo Honda Nature communications 17.1. 2026/05/16
-
Microfluidic post-insertion preparation and evaluation of RGD- and PEG-modified macrophage-derived small extracellular vesicles Mizuki Umino,Longjian Geng,Yusuke Ushiroda,Makoto Matsumoto,Hidefumi Mukai,Shigeru Kawakami Drug Metabolism and Pharmacokinetics 101538-101538 2026/04
-
Metabolic positron emission tomography imaging and tumor growth inhibition during the Q neuron-induced hibernation-like state in mice. Shoko Nomura,Wakiko Arakaki,Akari Kato,Naomi Fujie,Kiyomi Ishikawa,Ayaka Wataki,Hiroaki Ono,Tsuyoshi Tahara,Yasuhiro Wada,Yasuyoshi Watanabe,Hisashi Doi,Genshiro A Sunagawa,Hidefumi Mukai Biochemical and biophysical research communications 800.153268-153268 2026/01/12
-
Targeted Delivery of VEGF-siRNA to Glioblastoma Using Orientation-Controlled Anti-PD-L1 Antibody-Modified Lipid Nanoparticles. Ayaka Matsuo-Tani,Makoto Matsumoto,Takeshi Hiu,Mariko Kamiya,Longjian Geng,Riku Takayama,Yusuke Ushiroda,Naoya Kato,Hikaru Nakamura,Michiharu Yoshida,Hidefumi Mukai,Takayuki Matsuo,Shigeru Kawakami Pharmaceutics 17.10. 2025/10/04
-
Positron Emission Tomography-Based Pharmacokinetics of mRNA–Lipid Nanoparticles: A Study Quantifying the ApoE and Macrophage Contribution Kohta Mohri,Takayuki Miyazaki,Shota Warashina,Maiko Takahashi,Qin Ren,Riho Iida,Yasuhiro Wada,Kazuya Maeda,Yasuyoshi Watanabe,Yuta Suzuki,Hidefumi Mukai ACS Applied Materials & Interfaces 2025/08/03
-
Direct delivery of immune modulators to tumour-infiltrating lymphocytes using engineered extracellular vesicles. Xiabing Lyu,Tomoyoshi Yamano,Kanto Nagamori,Shota Imai,Toan Van Le,Dilireba Bolidong,Makie Ueda,Shota Warashina,Hidefumi Mukai,Seigo Hayashi,Kazutaka Matoba,Taito Nishino,Rikinari Hanayama Journal of extracellular vesicles 14.4.e70035- 2025/04
-
Tumor-stromal opening via S. typhimurium VNP20009 administration for complete inhibition of refractory tumor growth with liposomal anticancer drugs Akari Kato,Shoko Nomura,Maiko Takahashi,Erike Widyasari Sukowati,Hideyoshi Harashima,Hidefumi Mukai Journal of Controlled Release 2025/02
-
Microfluidic post-insertion of polyethylene glycol lipids and KK or RGD high functionality and quality lipids in milk-derived extracellular vesicles. Longjian Geng,Makoto Matsumoto,Feijie Yao,Mizuki Umino,Mariko Kamiya,Hidefumi Mukai,Shigeru Kawakami European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 106929-106929 2024/10/08
-
Synthesis of a novel adapter lipid using Fc-region mediated antibody modification for post-insert preparation of transferrin receptor targeted messenger RNA-loaded lipid nanoparticles Naoya Kato,Narumi Moriya,Makoto Matsumoto,Ayaka Matsuo,Michiharu Yoshida,Takeshi Hiu,Takayuki Matsuo,Yuuki Takashima,Mariko Kamiya,Hidefumi Mukai,Shigeru Kawakami European Journal of Pharmaceutics and Biopharmaceutics 114468-114468 2024/08
|